Cervical Cancer and HPV Research

Cervical cancer is caused in nearly all cases by persistent infection with Human Papillomavirus, a sexually transmitted virus whose carcinogenic subtypes—particularly HPV 16 and 18—produce oncoproteins that disable key tumor-suppressor mechanisms in cervical epithelial cells. Epidemiologists working in this area track how HPV genotypes are distributed across populations, how cervical cancer incidence and mortality vary by region and demographic group, and how interventions like prophylactic vaccination and cytology-based screening alter those patterns over time. Globally, the disease remains a leading cause of cancer death among women in low- and middle-income countries where screening infrastructure is limited, making questions about optimal vaccine coverage, screening interval, and catch-up strategies in partially vaccinated cohorts especially pressing. Researchers are also working to understand why a small fraction of HPV infections progress to malignancy while most clear spontaneously, a gap that points toward host immune factors, viral integration dynamics, and co-infections as active areas of investigation.

Works

156,474

Total citations

2,057,081

Keywords

Human PapillomavirusCervical CancerHPV VaccinationEpidemiologyCancer IncidenceCytology Screening